SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001600132-18-000048
Filing Date
2018-04-05
Accepted
2018-04-05 17:03:11
Documents
3
Effectiveness Date
2018-04-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A blphproxyaapril2018.htm DEFA14A 11984
2 a2018notice1.jpg GRAPHIC 135272
3 a2018notice2.jpg GRAPHIC 135804
  Complete submission text file 0001600132-18-000048.txt   375823
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 18741283
SIC: 2834 Pharmaceutical Preparations